Identifying Predictive Factors for Metabolic Dysfunction-Related Steatotic Liver Disease (MASLD) in Patients with Cardio-Metabolic Risk: A Multicenter Cross-Sectional Analysis from North East Ethiopia

• by Getachew Bizuneh Aydagnuhm, Aklile Semu Tefera, Gebru Tesfaw Getahun, Ermiyas Endewunet Melaku

• February 7, 2026

Beyond the tumor: the role of the gut microbiome in triple-negative breast cancer

• by Armina Saadatkhah, Laura Nicholson, Thomas A. Buchholz, Lee Hong

• May 22, 2026

Frontline Pharma: Sarah O’Keeffe

Ahead of HPLC 2026, Eli Lilly’s Sarah O’Keeffe reflects on leadership, collaboration, and the analytical advances helping bring increasingly complex medicines to patients

• by James Strachan

• May 8, 2026

• 16 min

Laparoscopic Roux-en-Y Gastric Bypass with the Maestro™ System: a Novel Collaborative Robotic Platform

• by Dan Azagury, Fabrice Leclerc, Elisa Reitano, Marius Nedelcu, Henry Mercoli

• May 14, 2026